CLEVELAND (WJW) — Jennifer Frederick never thought it would happen to her. She was 49 and active — until a strange lump ...

Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...

Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of ...

Exelixis EXEL underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing ...

Skin cancer is the most common cancer globally, but it’s also one of the most treatable—if caught early. That’s where the ...

City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Over the past three decades, the treatment of malignant central nervous system (CNS) tumors has become increasingly challenging, with only a few therapeutic ...

Immunosuppressive factors prevent killer T cells from defeating brain tumors that arise from primary breast cancer.

soton.ac.uk Background With significant developments in the management of metastatic breast cancer, the trajectory of progressive breast cancer is becoming increasingly complex with little ...